-
Vaccinating vampire bats against rabies can help prevent the spread of the disease to livestock and humans. NPR's Scott Simon talks with epidemiologist Tonie Rocke about a new way to vaccinate bats.
-
Courtesy Guilford CountyWhile the building remains closed, officials say residents seeking assistance can visit the Family Justice Center in High Point.
-
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet. -
The Trump Administration's financial cuts to global development programs pose a challenge for organizations fighting deadly infectious diseases both in the U.S. and abroad.
-
According to the American Psychiatric Association, more than 30% of Americans say their sleep quality is poor or they aren’t getting enough sleep each night.
-
A recent study shows that top scavengers, like hyenas, can be beneficial for human health. But the same study reveals that scavenger populations are declining and could mean more disease for humans.
-
The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.
-
Atrium Health says it will invest $100 million to support the recruitment and retention of providers in the Yadkin Valley region. -
During the COVID-19 pandemic, skepticism of science and medicine broke down along partisan lines.
-
Rural hospitals that are dependent on Medicaid funding can tap into a $50 billion fund in President Trump's new tax cut and spending law, which cut Medicaid spending overall.
-
The U.S. has hit an unwelcome milestone in measles cases this year. The CDC is reporting 1,288 cases across the country. The disease was declared eliminated 25 years ago. -
A recent study shows that top scavengers, like hyenas, can be beneficial for human health. But the same study reveals that scavenger populations are declining and could mean more disease for humans.
